HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert W Nickells Selected Research

Histones (Histone)

11/2020Targeting HDAC3 in the DBA/2J spontaneous mouse model of glaucoma.
1/2018Targeting HDAC3 Activity with RGFP966 Protects Against Retinal Ganglion Cell Nuclear Atrophy and Apoptosis After Optic Nerve Injury.
1/2016Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells.
9/2014Histone deacetylase 3 (HDAC3) plays an important role in retinal ganglion cell death after acute optic nerve injury.
3/2013Nuclear atrophy of retinal ganglion cells precedes the bax-dependent stage of apoptosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert W Nickells Research Topics

Disease

11Glaucoma
10/2021 - 07/2002
9Ganglion Cysts (Ganglion)
11/2020 - 02/2004
7Optic Nerve Injuries
11/2020 - 07/2005
4Neoplasms (Cancer)
01/2016 - 09/2002
3Mitochondrial Diseases (Mitochondrial Disease)
05/2021 - 02/2004
3Atrophy
01/2018 - 09/2014
2Optic Nerve Diseases (Optic Neuropathy)
04/2016 - 01/2016
2Ocular Hypertension (Glaucoma, Suspect)
04/2007 - 10/2006
2Retinoblastoma (Glioblastoma, Retinal)
10/2003 - 09/2002
1Hypertrophy
10/2023
1Choroidal Neovascularization
08/2017
1Wounds and Injuries (Trauma)
01/2016
1Neuroinflammatory Diseases
12/2015
1Neurodegenerative Diseases (Neurodegenerative Disease)
03/2007
1Hypercalcemia (Milk Alkali Syndrome)
09/2002
1Abscess
07/2002
1Blister (Bulla)
07/2002

Drug/Important Bio-Agent (IBA)

6Retinaldehyde (Retinal)IBA
10/2023 - 05/2004
5Histones (Histone)IBA
11/2020 - 03/2013
4HeterochromatinIBA
11/2020 - 03/2013
4Proteins (Proteins, Gene)FDA Link
11/2014 - 05/2004
3Messenger RNA (mRNA)IBA
03/2007 - 05/2004
2bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA
10/2021 - 07/2005
2RGFP966IBA
11/2020 - 01/2018
2Carisoprodol (Soma)FDA LinkGeneric
04/2016 - 10/2006
2Calcitriol (Calcijex)FDA LinkGeneric
10/2003 - 09/2002
2Vitamin DFDA LinkGeneric
10/2003 - 09/2002
1StaurosporineIBA
05/2021
1arginyl- 2,'6'- dimethyltyrosyl- lysyl- phenylalaninamideIBA
05/2021
1pigment epithelium-derived factorIBA
08/2017
1ThrombospondinsIBA
08/2017
1RNA (Ribonucleic Acid)IBA
01/2017
1Histone Deacetylases (Histone Deacetylase)IBA
01/2016
1Complement System Proteins (Complement)IBA
12/2015
1CytokinesIBA
11/2014
1NeurotoxinsIBA
11/2014
1histone deacetylase 3IBA
09/2014
1tozasertibIBA
03/2013
1Protein Kinase InhibitorsIBA
03/2013
1AntigensIBA
01/2013
1trichostatin A (A 300)IBA
03/2012
1Histone Deacetylase InhibitorsIBA
03/2012
1theasinensin AIBA
03/2012
1Apoptosis Regulatory ProteinsIBA
07/2010
1Peptides (Polypeptides)IBA
07/2010
1LigandsIBA
07/2010
1Glutamic Acid (Glutamate)FDA Link
04/2007
1Cone OpsinsIBA
10/2006
1Rod OpsinsIBA
10/2006
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
07/2005
1IronIBA
05/2004
1Ceruloplasmin (Ferroxidase)IBA
05/2004
1CopperIBA
05/2004
1Ferritins (Ferritin)IBA
05/2004
1AntioxidantsIBA
05/2004
1Transferrin (beta 2 Transferrin)IBA
05/2004
1CaspasesIBA
02/2004
1Bromodeoxyuridine (BrdU)IBA
10/2003
1ParaffinIBA
10/2003
1TransferasesIBA
10/2003
1Antineoplastic Agents (Antineoplastics)IBA
10/2003
1Ergocalciferols (Ergocalciferol)FDA LinkGeneric
09/2002
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
09/2002
1CalciumIBA
09/2002
1Calcitriol Receptors (Calcitriol Receptor)IBA
09/2002
1beta Subunit Luteinizing HormoneIBA
09/2002
1Mitomycin (Mitomycin-C)FDA LinkGeneric
07/2002

Therapy/Procedure

3Therapeutics
10/2021 - 02/2004
2Trabeculectomy (Trabeculoplasty)
04/2007 - 10/2006
1Axotomy
01/2016
1Laser Therapy (Surgery, Laser)
10/2006
1Post and Core Technique (Technique, Post)
10/2006
1Lasers (Laser)
05/2004
1Light Coagulation
05/2004
1Ligation
10/2003
1Aftercare (After-Treatment)
07/2002
1Filtering Surgery
07/2002